Skip to main content
DOK2 inhibits EGFR-mutated lung adenocarcinoma
Published Web Location
http://europepmc.org/articles/PMC3821857?pdf=renderNo data is associated with this publication.
Abstract
Somatic mutations in the EGFR proto-oncogene occur in ∼15% of human lung adenocarcinomas and the importance of EGFR mutations for the initiation and maintenance of lung cancer is well established from mouse models and cancer therapy trials in human lung ca
Many UC-authored scholarly publications are freely available on this site because of the UC's open access policies. Let us know how this access is important for you.